| Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725) |
|---|
| 11/16/2004 | US6818652 Heterocyclic retinoid compounds |
| 11/11/2004 | WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 11/10/2004 | EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 11/10/2004 | EP1474414A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent |
| 11/04/2004 | WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 11/04/2004 | WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 11/04/2004 | WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 11/04/2004 | US20040220055 Benzamidoacetonitriles and their use as antiparastics |
| 11/04/2004 | DE10315772A1 Chemische Verbindung und Verfahren für den intramolekularen Energietransfer zur Abspaltung von labilen funktionellen Gruppen aus chemischen Verbindungen Chemical compound and method for the intramolecular energy transfer to the cleavage of labile functional groups from chemical compounds |
| 11/04/2004 | CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease |
| 11/04/2004 | CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 11/04/2004 | CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 11/03/2004 | EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 11/03/2004 | CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar) |
| 11/03/2004 | CN1173967C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 11/03/2004 | CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 10/27/2004 | EP1469851A1 Melanocortin receptor agonists |
| 10/27/2004 | EP0970073B1 Process for preparing eprosartan |
| 10/26/2004 | US6809207 Amino acid derivatives |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089529A1 Method for the intramolecular energy transfer for the cleavage of labile functional group from biomolecules and the protected biomolecules |
| 10/21/2004 | US20040209942 treating cancer and apoptosis-associated disorders using cell cycle checkpoint activation modulators; also screening for the modulators |
| 10/21/2004 | US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/20/2004 | EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 10/19/2004 | US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects |
| 10/14/2004 | WO2004087686A2 Benzopyran compounds useful for treating inflammatory conditions |
| 10/14/2004 | US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 10/14/2004 | CA2520724A1 Benzopyran compounds useful for treating inflammatory conditions |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803381 Carbamic acid derivatives |
| 10/06/2004 | EP1463495A2 Agents and methods for treatment of cancer |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 09/30/2004 | WO2004058143A3 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 09/30/2004 | US20040192578 High specificity anticancer drug design process |
| 09/29/2004 | CN1533386A Slfonium salts, methods for their preparation and use therof as photoinitiators for radiation curable systems |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/22/2004 | EP1458704A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 09/22/2004 | EP1458674A1 Beta-amino-alpha-cyanoacrylates and their use as herbicides |
| 09/22/2004 | EP0879231B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 09/22/2004 | CN1531525A Organic compounds |
| 09/21/2004 | CA2256718C Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 09/16/2004 | WO2004078742A1 Thiolactones |
| 09/16/2004 | US20040181067 Tri(cyclo) substituted amide compounds |
| 09/16/2004 | US20040180939 Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
| 09/15/2004 | CN1166664C Cycermanone quaternary antifungal compound |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 09/08/2004 | EP0785782B1 Use of disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid-like activity |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171670 Neurological diseases and disorders; such as 3-fluoro-10,11-dihydro-5-(2-aminoethyl)-5H-dibenzo[a,d]cycloheptene |
| 09/01/2004 | EP1451147A1 Amino acid derivatives |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/31/2004 | US6784202 Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation |
| 08/26/2004 | WO2004072031A2 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | US20040167182 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 08/26/2004 | US20040167131 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 08/26/2004 | CA2515670A1 Phenylacetamides and their use as glucokinase modulators |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/25/2004 | EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/18/2004 | EP1446399A1 Piperazine derivatives having sst1 antagonistic activity |
| 08/18/2004 | CN1162425C 4-hydroxyl-piperidine derivative |
| 08/12/2004 | WO2004045557A3 Novel lapachone compounds and methods of use thereof |
| 08/12/2004 | WO2004007531A3 Activated checkpoint therapy and methods of use thereof |
| 08/12/2004 | WO2002076395A3 Agents and methods for treatment of cancer |
| 08/11/2004 | CN1520325A Antitumoral formulations of thioxanthenone |
| 08/11/2004 | CN1161331C Hydrazine derivatives |
| 08/10/2004 | US6774133 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
| 08/05/2004 | WO2004021969A3 Non-nucleoside reverse transcriptase inhibitors |
| 08/04/2004 | EP1442032A1 Heterocyclic retinoid compounds |
| 07/29/2004 | US20040147482 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 07/28/2004 | EP1334096B1 Friedel-craft process for the preparation of thioxanthones |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1515566A Substituted chromene derivative for curing inflammation |
| 07/27/2004 | US6767919 High specificity anticancer agents |
| 07/22/2004 | WO2004037879A3 Monomers containing at least one biaryl unit and polymers and derivatives prepared therefrom |
| 07/22/2004 | WO2004024086A3 Compounds, compositions and methods |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/21/2004 | CN1513849A Mannitol and sorbierite derivative |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004058143A2 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
| 07/15/2004 | US20040138183 Bactericides; anticarcinogenic agents; modulation of gene expression; therapy for antibiotic resistant bacteria |
| 07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1436288A1 Multi-functional thioxanthone photoinitiators |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |